{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('CDASH-2-3-IG.json') as file:\n",
    "    data = json.load(file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "AG | Procedure Agents | An interventions domain that contains the agents administered to the subject as part of a procedure or assessment, as opposed to drugs, medications and therapies administered with therapeutic intent. (Source: CDISC Controlled Terminology, DOMAIN, C117755, 2023-6-28)\n",
      "CM | Concomitant/Prior Medications | An interventions domain that contains concomitant and prior medications used by the subject, such as those given on an as needed basis or condition-appropriate medications. (Source: CDISC Controlled Terminology, DOMAIN, C49568, 2023-6-28)\n",
      "EC | Exposure as Collected | An interventions domain that contains information about protocol-specified study treatment administrations, as collected. (Source: CDISC Controlled Terminology, DOMAIN, C117466, 2023-6-28)\n",
      "EX | Exposure | An interventions domain that contains the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject. (Source: CDISC Controlled Terminology, DOMAIN, C49587, 2023-6-28)\n",
      "ML | Meal Data | An interventions domain that contains information describing a subject's food product consumption. (Source: CDISC Controlled Terminology, DOMAIN, C49604, 2023-6-28)\n",
      "PR | Procedures | An interventions domain that contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. (Source: CDISC Controlled Terminology, DOMAIN, C102700, 2023-6-28)\n",
      "SU | Substance Use | An interventions domain that contains substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use. (Source: CDISC Controlled Terminology, DOMAIN, C49615, 2023-6-28)\n",
      "AE | Adverse Events | An events domain that contains data describing untoward medical occurrences in a patient or subjects that are administered a pharmaceutical product and which may not necessarily have a causal relationship with the treatment. (Source: CDISC Controlled Terminology, DOMAIN, C49562, 2023-6-28)\n",
      "CE | Clinical Events | An events domain that contains clinical events of interest that would not be classified as adverse events. (Source: CDISC Controlled Terminology, DOMAIN, C85441, 2023-6-28)\n",
      "DS | Disposition | An events domain that contains information encompassing and representing data related to subject disposition. (Source: CDISC Controlled Terminology, DOMAIN, C49576, 2023-6-28)\n",
      "DV | Protocol Deviations | An events domain that contains protocol violations and deviations during the course of the study. (Source: CDISC Controlled Terminology, DOMAIN, C49585, 2023-6-28)\n",
      "HO | Healthcare Encounters | A events domain that contains data for inpatient and outpatient healthcare events (e.g., hospitalization, nursing home stay, rehabilitation facility stay, ambulatory surgery). (Source: CDISC Controlled Terminology, DOMAIN, C117757, 2023-6-28)\n",
      "MH | Medical History | An events domain that contains data that includes the subject's prior medical history at the start of the trial. (Source: CDISC Controlled Terminology, DOMAIN, C49603, 2023-6-28)\n",
      "SA | Serious Adverse Events | An events domain that contains data describing untoward medical occurrences considered serious (SAE) in a patient or subjects that are administered a pharmaceutical product and which may not necessarily have a causal relationship with the treatment. (Source: CDISC Controlled Terminology, DOMAIN, C177945, 2023-6-28)\n",
      "CP | Cell Phenotype Findings | A findings domain that contains data related to the characterization of cell phenotype, lineage, and function based on expression of specific markers in single cell or particle suspensions. (Source: CDISC Controlled Terminology, DOMAIN, C181319, 2023-6-28)\n",
      "CV | Cardiovascular System Findings | A findings domain that contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. (Source: CDISC Controlled Terminology, DOMAIN, C102605, 2023-6-28)\n",
      "DA | Product Accountability | A findings domain that contains the accountability of study product, such as information on the receipt, dispensing, return, and packaging. (Source: CDISC Controlled Terminology, DOMAIN, C49578, 2023-6-28)\n",
      "DD | Death Details | A findings domain that contains the diagnosis of the cause of death for a subject. (Source: CDISC Controlled Terminology, DOMAIN, C95087, 2023-6-28)\n",
      "EG | ECG Test Results | A findings domain that contains ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived. (Source: CDISC Controlled Terminology, DOMAIN, C49626, 2023-6-28)\n",
      "GF | Genomics Findings | A findings domain that contains data related to the structure, function, evolution, mapping, and editing of subject and non-host organism genomic material of interest. This domain includes but is not limited to assessments and results for genetic variation and transcription, and summary measures derived from these assessments. The GF domain is used for findings from characteristics assessed from nucleic acids and may include subsequent inferences and/or predictions about related proteins/amino acids. (Source: CDISC Controlled Terminology, DOMAIN, C181320, 2023-6-28)\n",
      "IE | Inclusion/Exclusion Criteria Not Met | A findings domain that contains those criteria that cause the subject to be in violation of the inclusion/exclusion criteria. (Source: CDISC Controlled Terminology, DOMAIN, C61536, 2023-6-28)\n",
      "LB | Laboratory Test Results | A findings domain that contains laboratory test data such as hematology, clinical chemistry and urinalysis. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains. (Source: CDISC Controlled Terminology, DOMAIN, C49592, 2023-6-28)\n",
      "MB | Microbiology Specimen | A findings domain that represents non-host organisms identified including bacteria, viruses, parasites, protozoa and fungi. (Source: CDISC Controlled Terminology, DOMAIN, C49602, 2023-6-28)\n",
      "MI | Microscopic Findings | A findings domain that contains histopathology findings and microscopic evaluations. (Source: CDISC Controlled Terminology, DOMAIN, C95095, 2023-6-28)\n",
      "MK | Musculoskeletal System Findings | A findings domain that contains physiological and morphological findings related to the system of muscles, tendons, ligaments, bones, joints, and associated tissues. (Source: CDISC Controlled Terminology, DOMAIN, C102674, 2023-6-28)\n",
      "MS | Microbiology Susceptibility | A findings domain that represents drug susceptibility testing results only. This includes phenotypic testing (where drug is added directly to a culture of organisms) and genotypic tests that provide results in terms of susceptible or resistant. Drug susceptibility testing may occur on a wide variety of non-host organisms, including bacteria, viruses, fungi, protozoa and parasites. (Source: CDISC Controlled Terminology, DOMAIN, C61531, 2023-6-28)\n",
      "NV | Nervous System Findings | A findings domain that contains physiological and morphological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses. (Source: CDISC Controlled Terminology, DOMAIN, C102677, 2023-6-28)\n",
      "OE | Ophthalmic Examinations | A findings domain that contains tests that measure a person's ocular health and visual status, to detect abnormalities in the components of the visual system, and to determine how well the person can see. (Source: CDISC Controlled Terminology, DOMAIN, C147180, 2023-6-28)\n",
      "PC | Pharmacokinetics Concentrations | A findings domain that contains concentrations of drugs or metabolites in fluids or tissues as a function of time. (Source: CDISC Controlled Terminology, DOMAIN, C49606, 2023-6-28)\n",
      "PE | Physical Examination | A findings domain that contains findings observed during a physical examination where the body is evaluated by inspection, palpation, percussion, and auscultation. (Source: CDISC Controlled Terminology, DOMAIN, C49608, 2023-6-28)\n",
      "RE | Respiratory System Findings | A findings domain that contains physiological and morphological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. (Source: CDISC Controlled Terminology, DOMAIN, C95098, 2023-6-28)\n",
      "RP | Reproductive System Findings | A findings domain that contains physiological and morphological findings related to the male and female reproductive systems. (Source: CDISC Controlled Terminology, DOMAIN, C102707, 2023-6-28)\n",
      "RS | Disease Response and Clin Classification | A findings domain for the assessment of disease response to therapy, or clinical classification based on published criteria. (Source: CDISC Controlled Terminology, DOMAIN, C107097, 2023-6-28)\n",
      "SC | Subject Characteristics | A findings domain that contains subject-related data not collected in other domains. (Source: CDISC Controlled Terminology, DOMAIN, C49610, 2023-6-28)\n",
      "TR | Tumor/Lesion Results | A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors, lesions, or locations of interest identified in the Tumor/Lesion Identification (TU) domain. (Source: CDISC Controlled Terminology, DOMAIN, C106578, 2023-6-28)\n",
      "TU | Tumor/Lesion Identification | A findings domain that represents data that uniquely identifies tumors, lesions, or locations of interest under study. (Source: CDISC Controlled Terminology, DOMAIN, C106577, 2023-6-28)\n",
      "UR | Urinary System Findings | A findings domain that contains physiological and morphological findings related to the urinary tract, including the organs involved in the creation and excretion of urine such as the kidneys, ureters, bladder and urethra. (Source: CDISC Controlled Terminology, DOMAIN, C102726, 2023-6-28)\n",
      "VS | Vital Signs | A findings domain that contains measurements including but not limited to blood pressure, temperature, respiration, body surface area, body mass index, height and weight. (Source: CDISC Controlled Terminology, DOMAIN, C49622, 2023-6-28)\n",
      "FA | Findings About Events or Interventions | A findings domain that contains the findings about an event or intervention that cannot be represented within an events or interventions domain record or as a supplemental qualifier. (Source: CDISC Controlled Terminology, DOMAIN, C85442, 2023-6-28)\n",
      "SR | Skin Response | A findings about domain for submitting dermal responses to antigens. (Source: CDISC Controlled Terminology, DOMAIN, C112420, 2023-6-28)\n",
      "CO | Comments | A special-purpose domain that contains comments that may be collected alongside other data. (Source: CDISC Controlled Terminology, DOMAIN, C49569, 2023-6-28)\n",
      "DM | Demographics | A special-purpose domain that includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects. (Source: CDISC Controlled Terminology, DOMAIN, C49572, 2023-6-28)\n"
     ]
    }
   ],
   "source": [
    "# Parse and return the extracted CDASH-IG classes\n",
    "classes = data['classes']\n",
    "\n",
    "for c in classes:\n",
    "    domains = c['domains']\n",
    "    \n",
    "    for d in domains:\n",
    "\n",
    "        #print(d['_links']['self'])\n",
    "        print(d['name'],'|',d['label'],'|',d['description'])\n",
    "\n",
    "        '''\n",
    "        try:\n",
    "            print(d['_links']['scenarios'])\n",
    "        except:\n",
    "            print('No scenarios for this domain')\n",
    "        #print(d['name'], d['label'], d['description'])\n",
    "        '''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\nin CDISC eCRF portal but not in CDISC Library API:\\n\\nAcute Respiratory Infection - Pathogen Testing\\nClinical Classification - no CRF\\nDiabetes Hypoglycemic Event\\nDrug Accountability - Horizontal & Vertical\\nECG Test Results - Central Reading\\n\\n'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Compare which forms are available per the CDISC Library API vs. available in CDISC eCRF Library\n",
    "'''\n",
    "in CDISC eCRF portal but not in CDISC Library API:\n",
    "\n",
    "Acute Respiratory Infection - Pathogen Testing\n",
    "Clinical Classification - no CRF\n",
    "Diabetes Hypoglycemic Event\n",
    "Drug Accountability - Horizontal & Vertical\n",
    "ECG Test Results - Central Reading\n",
    "\n",
    "'''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Special-Purpose This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). (Source: CDISC Controlled Terminology, GNRLOBSC, C103374, 2023-06-30)\n",
      "AG | Procedure Agents\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Category for Agent\n",
      "Subcategory for Agent\n",
      "Any Procedure Agent Taken\n",
      "AG Sponsor-Defined Identifier\n",
      "Reported Agent Name\n",
      "AG Prespecified\n",
      "AG Occurrence\n",
      "AG Dose per Administration\n",
      "Procedure Agents Dose Description\n",
      "AG Dose Units\n",
      "AG Dose Form\n",
      "AG Dosing Frequency per Interval\n",
      "AG Route of Administration\n",
      "Procedure Agent Start Date\n",
      "Procedure Agent Start Time\n",
      "Prior Procedure Agents\n",
      "Ongoing Procedure Agents\n",
      "Procedure Agents End Date\n",
      "Procedure Agents End Time\n",
      "Standardized Agent Name\n",
      "AG Agent Class\n",
      "AG Agent Class Code\n",
      "CM | Concomitant/Prior Medications\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Category for Medication\n",
      "Subcategory for Medication\n",
      "Any Concomitant Medications Taken\n",
      "CM Sponsor-Defined Identifier\n",
      "Reported Name of Drug, Med, or Therapy\n",
      "CM Prespecified\n",
      "CM Occurrence\n",
      "Concomitant Meds Active Ingredients\n",
      "CM Indication\n",
      "Related Adverse Event ID\n",
      "Related Medical History Event ID\n",
      "CM Dose per Administration\n",
      "Concomitant Meds Dose Description\n",
      "CM Total Daily Dose\n",
      "CM Dose Units\n",
      "CM Dose Form\n",
      "CM Dosing Frequency per Interval\n",
      "CM Route of Administration\n",
      "Concomitant Meds Start Date\n",
      "Concomitant Meds Start Time\n",
      "Prior Concomitant Meds\n",
      "Ongoing Concomitant Meds\n",
      "Concomitant Meds End Date\n",
      "Concomitant Meds End Time\n",
      "Reason for Treatment Discontinuation\n",
      "Standardized Medication Name\n",
      "CM Medication Class\n",
      "CM Medication Class Code\n",
      "ATC Level 1 Description\n",
      "ATC Level 1 Code\n",
      "ATC Level 2 Description\n",
      "ATC Level 2 Code\n",
      "ATC Level 3 Description\n",
      "ATC Level 3 Code\n",
      "ATC Level 4 Description\n",
      "ATC Level 4 Code\n",
      "ATC Level 5 Description\n",
      "ATC Level 5 Code\n",
      "EC | Exposure as Collected\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Epoch\n",
      "Any Study Treatment Taken\n",
      "Category of Treatment\n",
      "Subcategory of Treatment\n",
      "Treatment\n",
      "Exposure as Collected Prespecified\n",
      "Exposure as Collected Occurrence\n",
      "Exposure Reason for Occur Value\n",
      "Exposure as Collected Mood\n",
      "Exposure as Collected Reference ID\n",
      "Lot Number\n",
      "Exposure as Collected Fasting Status\n",
      "Exposure as Collected Dose Form\n",
      "Exposure as Collected Start Date\n",
      "Exposure as Collected Start Time\n",
      "Exposure as Collected End Date\n",
      "Exposure as Collected End Time\n",
      "Exposure as Collected Dose Description\n",
      "Exposure as Collected Dose Units\n",
      "EC Dosing Frequency per Interval\n",
      "EC Route of Administration\n",
      "Intended Dose Regimen\n",
      "Dose Adjusted\n",
      "Reason for Dose Adjustment\n",
      "EC Exposure Interrupted\n",
      "EC Interruption Duration\n",
      "EC Interruption Duration Units\n",
      "EC Location of Dose Administration\n",
      "Exposure as Collected Laterality\n",
      "Exposure as Collected Directionality\n",
      "EC Vehicle Amount\n",
      "EC Vehicle Amount Units\n",
      "Exposure as Collected Infusion Rate\n",
      "Exposure as Collected Infusion Rate Unit\n",
      "EC Planned Time Point Name\n",
      "Completed Treatment\n",
      "EX | Exposure\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Epoch\n",
      "Any Study Treatment Taken\n",
      "Category of Treatment\n",
      "Subcategory of Treatment\n",
      "Name of Treatment\n",
      "Exposure Reference ID\n",
      "Lot Number\n",
      "Exposure Fasting Status\n",
      "Exposure Dose Form\n",
      "Exposure Start Date\n",
      "Exposure Start Time\n",
      "Exposure End Date\n",
      "Exposure End Time\n",
      "Exposure Dose Description\n",
      "Exposure Dose Unit\n",
      "Exposure Dosing Frequency per Interval\n",
      "Exposure Route of Administration\n",
      "Intended Dose Regimen\n",
      "Dose Adjusted\n",
      "Reason for Dose Adjustment\n",
      "EX Exposure Interrupted\n",
      "Exposure Interruption Duration\n",
      "Exposure Interruption Duration Units\n",
      "Exposure Location of Dose Administration\n",
      "Exposure Vehicle Amount\n",
      "Exposure Vehicle Amount Units\n",
      "Exposure Infusion Rate\n",
      "Exposure Infusion Rate Unit\n",
      "Exposure Planned Time Point Name\n",
      "Completed Treatment\n",
      "Exposure Laterality\n",
      "Exposure Directionality\n",
      "ML | Meal Data\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Category for Meal\n",
      "Subcategory for Meal\n",
      "Any Meal Taken\n",
      "ML Sponsor-Defined Identifier\n",
      "Name of Meal or Food Product\n",
      "ML Prespecified\n",
      "ML Occurrence\n",
      "Reason for Occur Value\n",
      "ML Reason\n",
      "Related Clinical Event ID\n",
      "Dose\n",
      "Dose Description\n",
      "Dose Units\n",
      "Meal Start Date\n",
      "Meal Start Time\n",
      "Meal End Date\n",
      "Meal End Time\n",
      "Standardized Meal Name\n",
      "Modified Reported Term\n",
      "PR | Procedures\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Any Procedures Performed\n",
      "Procedure Category\n",
      "Procedure Subcategory\n",
      "Procedure Sponsor-Defined Identifier\n",
      "Reported Name of Procedure\n",
      "Standardized Procedure Name\n",
      "Modified Procedure Name\n",
      "Procedure Prespecified\n",
      "Procedure Occurrence\n",
      "Procedure Reason for Occur Value\n",
      "Procedure Reason Not Done\n",
      "Prior Procedure\n",
      "Procedure Start Date\n",
      "Ongoing Procedure\n",
      "Procedure End Date\n",
      "Procedure Indication\n",
      "Related Adverse Event ID\n",
      "Related Medical History Event ID\n",
      "Procedure Dose Description\n",
      "Procedure Dose Unit\n",
      "Procedure Frequency per Interval\n",
      "Procedure Route of Administration\n",
      "Location of Procedure\n",
      "Procedure Laterality\n",
      "Procedure Directionality\n",
      "Procedure Portion or Totality\n",
      "Procedure Fasting Status\n",
      "Procedure Intended Dose Regimen\n",
      "Procedure Adjusted\n",
      "Reason for Procedure Adjustment\n",
      "Completed Procedure\n",
      "Procedure Interrupted\n",
      "Reason Procedure Interrupted\n",
      "Procedure Interruption Duration\n",
      "Procedure Interruption Duration Units\n",
      "Procedure Lowest Level Term\n",
      "Procedure Lowest Level Term Code\n",
      "Procedure Preferred Term Code\n",
      "Procedure High Level Term\n",
      "Procedure High Level Term Code\n",
      "Procedure High Level Group Term\n",
      "Procedure High Level Group Term Code\n",
      "PR Primary System Organ Class\n",
      "PR Primary System Organ Class Code\n",
      "SU | Substance Use\n",
      "Study Identifier\n",
      "Study Site Identifier\n",
      "Subject Identifier for the Study\n",
      "Reported Name of Substance\n",
      "Category for Substance Use\n",
      "Subcategory for Substance Use\n",
      "SU Prespecified\n",
      "Any Substance Used\n",
      "Never Current Former Usage\n",
      "Substance Use Sponsor-Defined Identifier\n",
      "Reason Substance Use Not Collected\n",
      "Substance Dose Description\n",
      "Substance Use Frequency per Interval\n",
      "Substance Use Start Date\n",
      "Substance Use End Date\n",
      "Substance Use Collected Duration\n",
      "Substance Use Collected Duration Unit\n",
      "Modified Substance Name\n",
      "Standardized Substance Name\n"
     ]
    }
   ],
   "source": [
    "# Parse and return the extracted CDASH-IG classes\n",
    "classes = data['classes']\n",
    "\n",
    "for c in classes:\n",
    "\n",
    "    class_name = c['_links']['self']['title']\n",
    "    description = c['description']\n",
    "\n",
    "    print(class_d, description)\n",
    "\n",
    "    domains = c['domains']\n",
    "\n",
    "    \n",
    "    for d in domains:\n",
    "\n",
    "        print(d['name'],'|',d['label'])\n",
    "        #print(d['name'],'|',d['label'],'|',d['description'])\n",
    "\n",
    "\n",
    "        fields = d['fields']\n",
    "\n",
    "        for f in fields:\n",
    "\n",
    "            field_name = f['_links']['self']['title']\n",
    "\n",
    "            print(field_name)\n",
    "\n",
    "    break\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "scdm_workshop_2024-RLQtTa-6",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "67ee1515d03873422e5acee950a92863f4595aca1599cf6a3f7c5f54e5ab1571"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
